PF-AtlasClinical Trials › NCT07147803

Sleep Quality in Patients With Non-cystic Fibrosis Bronchiectasis

Pittsburgh Sleep Quality Index · Not specified

Registry ID
NCT07147803
Phase
Not specified
Status
Active, not recruiting
Drug / intervention
Pittsburgh Sleep Quality Index
Sponsor
Assiut University
Start
2025-09-30
Enrollment
60
Locations
1

About this trial

Non-cystic fibrosis (non-CF) bronchiectasis is a chronic, heterogeneous airway disease characterized by irreversible bronchial dilatation, persistent airway infection, and neutrophilic inflammation that together drive daily cough, sputum production, recurrent exacerbations, and progressive functional decline. Sleep is a key determinant of Health-Related Quality of Life (HRQoL) and cardiometabolic health. In chronic lung diseases, nocturnal hypoxemia, cough, dyspnea, and systemic inflammation commonly disrupt sleep continuity and architecture. In bronchiectasis specifically, several studies show high rates of poor sleep quality using the Pittsburgh Sleep Quality Index (PSQI), with \~50-60% of clinically stable patients classified as "poor sleepers," often accompanied by daytime dysfunction. Poor sleep correlates with disease severity indices and symptoms such as nocturnal cough.

View NCT07147803 on ClinicalTrials.gov →

Explore related

Medical disclaimer. This page summarizes public trial data for NCT07147803 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.